To the Editor.—
In reply to the letter of Rabins et al (1983;249:353) regarding the use of anticoagulant therapy for senility, I would like to clarify some points. It is true that our studies were not "controlled," except when some patients served as their own control, when their conditions worsened when anticoagulant therapy was discontinued and improved when therapy began again. But there was a control study done in Montreal by Ratner et al1,2 that confirms my findings of benefit from anticoagulant therapy in senility. Their study also confirms our findings as to the relative safety of anticoagulant therapy in senile persons—the Montreal group had no complications during a one-year period.In regard to the risks of falling, in 18 years, only one of our patients (and she suffered from cortical blindness and severe confusion) had serious complications from a fall, and she fell down a whole flight of
Walsh AC. Anticoagulant Therapy for Senile Dementia. JAMA. 1983;249(24):3305. doi:10.1001/jama.1983.03330480021018
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: